loader
Please Wait
Applying Filters...
menu
    • menu

    Technical details about Daridorexant Hydrochloride, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Daridorexant Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 49,323Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Act-541468a, Act-541468 hydrochloride, Nemorexant hydrochloride, Quviviq, 9x9581n56r, 1792993-84-0
    Molecular Formula
    C23H24Cl2N6O2
    Molecular Weight
    487.4  g/mol
    InChI Key
    HJVGDXBEMFHGKI-BQAIUKQQSA-N
    FDA UNII
    9X9581N56R
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    [(2S)-2-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-2-methylpyrrolidin-1-yl]-[5-methoxy-2-(triazol-2-yl)phenyl]methanone;hydrochloride
    2.1.2 InChI
    InChI=1S/C23H23ClN6O2.ClH/c1-14-17(24)6-7-18-20(14)28-22(27-18)23(2)9-4-12-29(23)21(31)16-13-15(32-3)5-8-19(16)30-25-10-11-26-30;/h5-8,10-11,13H,4,9,12H2,1-3H3,(H,27,28);1H/t23-;/m0./s1
    2.1.3 InChI Key
    HJVGDXBEMFHGKI-BQAIUKQQSA-N
    2.1.4 Canonical SMILES
    CC1=C(C=CC2=C1N=C(N2)C3(CCCN3C(=O)C4=C(C=CC(=C4)OC)N5N=CC=N5)C)Cl.Cl
    2.1.5 Isomeric SMILES
    CC1=C(C=CC2=C1N=C(N2)[C@@]3(CCCN3C(=O)C4=C(C=CC(=C4)OC)N5N=CC=N5)C)Cl.Cl
    2.2 Other Identifiers
    2.2.1 UNII
    9X9581N56R
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Act-541468a

    2. Act-541468 Hydrochloride

    3. Nemorexant Hydrochloride

    4. Quviviq

    5. 9x9581n56r

    6. 1792993-84-0

    7. Unii-9x9581n56r

    8. Daridorexant Hydrochloride [usan]

    9. Methanone, ((2s)-2-(6-chloro-7-methyl-1h-benzimidazol-2-yl)-2-methyl-1-pyrrolidinyl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)-, Hydrochloride (1:1)

    10. Chembl4650216

    11. Schembl16767284

    12. Ex-a7813

    13. Daridorexant Hydrochloride [jan]

    14. Ts-09376

    15. Daridorexant Hydrochloride [who-dd]

    16. ((2s)-2-(5-chloro-4-methyl-1h-benzimidazol-2-yl)-2-methylpyrrolidin-1-yl)(5- Methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone Hydrochloride (1:1)

    17. ((2s)-2-(5-chloro-4-methyl-1h-benzimidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone Hydrochloride (1:1)

    18. ((2s)-2-(5-chloro-4-methyl-1h-benzimidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone Monohydrochloride

    19. (s)-(2-(5-chloro-4-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone Hydrochloride

    2.4 Create Date
    2015-06-29
    3 Chemical and Physical Properties
    Molecular Weight 487.4 g/mol
    Molecular Formula C23H24Cl2N6O2
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count4
    Exact Mass g/mol
    Monoisotopic Mass g/mol
    Topological Polar Surface Area88.9
    Heavy Atom Count33
    Formal Charge0
    Complexity693
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Indication

    Quviviq is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.

    5 Pharmacology and Biochemistry
    5.1 ATC Code

    N05